Mirae Asset Global Investments Co. Ltd. Buys New Stake in Cognex Corporation $CGNX

Key Points

• Mirae Asset Global Investments opened a new Cognex position, buying 25,589 shares valued at approximately $1.55 million in the third quarter. Institutional investors and hedge funds own 88.12% of the stock.
• Cognex reported quarterly earnings of $0.53 per share, slightly above estimates, while revenue of $313.39 million narrowly missed forecasts but rose 13% year over year.
• The company increased its quarterly dividend from $0.085 to $0.09 per share. Analysts’ consensus rating was “Moderate Buy,” with an average price target of $72.93.

Mirae Asset Global Investments Co. Ltd. bought a new stake in Cognex Corporation (NASDAQ:CGNX - Free Report) in the 3rd quarter, according to its most recent filing with the SEC. The fund bought 25,589 shares of the scientific and technical instruments company's stock, valued at approximately $1,552,000.

Several other large investors have also recently made changes to their positions in CGNX. BlackRock Inc. purchased a new position in Cognex in the second quarter valued at $1,158,123,000. Janus Henderson Group PLC boosted its stake in shares of Cognex by 81.0% during the 1st quarter. Janus Henderson Group PLC now owns 2,660,411 shares of the scientific and technical instruments company's stock worth $130,320,000 after acquiring an additional 1,190,434 shares in the last quarter. Jupiter Topco LLC acquired a new stake in shares of Cognex during the 2nd quarter valued at about $161,425,000. Arrowstreet Capital Limited Partnership grew its position in shares of Cognex by 115.6% during the 1st quarter. Arrowstreet Capital Limited Partnership now owns 2,033,091 shares of the scientific and technical instruments company's stock valued at $99,601,000 after acquiring an additional 1,090,092 shares during the period. Finally, Bank of New York Mellon Corp acquired a new stake in shares of Cognex during the 2nd quarter valued at about $129,348,000. 88.12% of the stock is currently owned by institutional investors and hedge funds.

Cognex Price Performance

CGNX opened at $47.78 on Friday. The firm has a market capitalization of $8.04 billion, a price-to-earnings ratio of 33.41 and a beta of 1.49. The company's 50 day simple moving average is $59.06 and its two-hundred day simple moving average is $58.04. Cognex Corporation has a 1-year low of $34.60 and a 1-year high of $72.88.

Cognex (NASDAQ:CGNX - Get Free Report) last posted its quarterly earnings results on Wednesday, November 4th. The scientific and technical instruments company reported $0.53 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.52 by $0.01. Cognex had a return on equity of 15.75% and a net margin of 21.50%. The business had revenue of $313.39 million during the quarter, compared to analyst estimates of $313.62 million. During the same period in the prior year, the business earned $0.33 earnings per share. The business's revenue was up 13.0% compared to the same quarter last year. On average, equities analysts anticipate that Cognex Corporation will post 1.70 earnings per share for the current fiscal year.

Cognex Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, December 3rd. Investors of record on Thursday, November 19th will be issued a $0.09 dividend. This is an increase from Cognex's previous quarterly dividend of $0.0850. This represents a $0.36 dividend on an annualized basis and a dividend yield of 0.8%. The ex-dividend date of this dividend is Thursday, November 19th. Cognex's payout ratio is currently 23.78%.

Wall Street Analysts Forecast Growth

CGNX has been the subject of several recent analyst reports. Robert W. Baird cut their price target on Cognex from $78.00 to $70.00 and set a "neutral" rating for the company in a research note on Wednesday, September 23rd. Cantor Fitzgerald raised their price objective on Cognex from $76.00 to $84.00 and gave the company an "overweight" rating in a report on Friday, August 7th. KeyCorp cut their price objective on Cognex from $80.00 to $65.00 and set an "overweight" rating for the company in a research report on Friday. Needham & Company LLC reduced their target price on Cognex from $80.00 to $70.00 and set a "buy" rating for the company in a research note on Friday. Finally, HSBC lowered Cognex from a "buy" rating to a "hold" rating and set a $65.00 target price on the stock. in a research report on Monday, August 10th. One research analyst has rated the stock with a Strong Buy rating, ten have given a Buy rating and seven have issued a Hold rating to the company. According to MarketBeat.com, the company has an average rating of "Moderate Buy" and a consensus target price of $72.93.

Trending Headlines about Cognex

Here are the key news stories impacting Cognex this week:

• Positive Sentiment: Cognex reported record Q3 results, with earnings of $0.53 per share beating estimates and revenue growing year over year. Management raised its 2026 revenue outlook to $1.14 billion–$1.16 billion and cited margin expansion and stronger logistics demand. Q3 earnings call outlook and margin expansion
• Positive Sentiment: The planned RealSense acquisition could add growth opportunities, while management is targeting further margin expansion. Cognex reports record third-quarter results and RealSense acquisition
• Positive Sentiment: The company raised its quarterly dividend by 5.9% to $0.09 per share, a modest signal of confidence in cash generation.
• Negative Sentiment: Several firms cut their price targets: Stephens lowered its target to $70, KeyCorp to $65, Needham to $70, and Truist to $57. The cuts may temper enthusiasm despite the improved outlook; ratings remain mostly overweight or buy, while Truist is at hold. Stephens price-target change

About Cognex

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.